FDA warning letter
Issue date
13 Jun 2019
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
9 Jul 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
FDA warning letter
Issue date
4 Feb 2019
Issuing office
Detroit District Office
Posted date
12 Feb 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs